Dr Yvette Kazungu

Biography

Yvette Kazungu is a postdoctoral researcher in molecular virology with a background in ribonucleic acid virus-host interactions and cross-talks with innate immunity. More recently, her research focus has veered into translational virology research including in vivo work and drug screening against viruses of clinical importance.

This includes a recent collaborative project which tested small antiviral compounds against SARS-CoV-2 in a humanised mouse model and established the immunophenotype profiles after treatment.

In her current project, Yvette uses reverse genetics and large scale random codon re-encoding to attenuate viruses and profile the differences in immune responses to infection and interventions in vivo.

Selected research publications

Inhibitors of protein glycosylation are active against the coronavirus severe acute respiratory syndrome coronavirus sars-cov-2 – Journal: Viruses – Published: 30th April 2021

Viral priming of cell intrinsic innate antiviral signaling by the unfolded protein response – Journal: Nature Communications – Published: 1st December 2019

View more publications